Gross Profit: Revenues from operations less the associated costs.
Tenax Therapeutics, Inc. (TENX) Gross Profit data is not available for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-17.80M |
|
-- |
|
|
Gross Profit |
-- |
$18.78M |
|
$-18.78M |
|
$0.98M |
|
$-17.80M |
|
$-17.80M |
|
$-17.80M |
|
$-17.80M |
|
$-17.80M |
|
$-17.80M |
|
$-18.78M |
|
$-18.78M |
|
50.87M |
|
50.87M |
|
$-0.35 |
|
$-0.35 |
|
| Balance Sheet Financials | |
$121.66M |
|
-- |
|
-- |
|
$121.66M |
|
$8.07M |
|
-- |
|
-- |
|
$8.07M |
|
$113.59M |
|
$113.59M |
|
$113.59M |
|
31.95M |
|
| Cash Flow Statement Financials | |
$-23.46M |
|
-- |
|
$43.87M |
|
$97.56M |
|
$117.98M |
|
$20.41M |
|
$6.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.46M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.67% |
|
-15.67% |
|
-14.63% |
|
-15.67% |
|
$3.56 |
|
$-0.46 |
|
$-0.46 |
|